$250 | Single User
$500 | Site License
$750 | Enterprise License

Protein Sciences Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile
[Lowest Price Guaranteed: $250]

Published by Global Data: 12 May 2016 | 12781 | In Stock
Related Topics: Business , Equity , Financial , Healthcare , Pharmaceuticals , Protein

Introduction

Summary

Protein Sciences Corporation (Protein Sciences) is a biotechnology company that develops and produces vaccines and proteins. The company’s products include proprietary vaccines, research antigens and others. Protein Sciences offers proprietary vaccines, such as FluBlok, which is used for the treatment of influenza disease; PanBlok, pandemic influenza vaccine candidate; and others. The company also provides various purified proteins and antibodies for the treatment of human and veterinary diseases including HIV influenza, and cancer It provides vaccines for the treatment of influenza, human papillomavirus, emerging pathogens, biodefense, prostate and breast cancer, diabetes, muscular dystrophy, genetically-based lipid disorders and CNS disorders. Protein Sciences is headquartered in Meriden, Connecticut, the US.

Protein Sciences Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.

- Business Description - A brief description of the company's operations.

- Key Employees - A list of the key executives of the company.

- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors - A list of the key competitors of the company.

- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table of Contents
for Protein Sciences Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • Table of Contents

    Table of Contents 2

    List of Tables 3

    List of Figures 4

    Protein Sciences Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5

    Protein Sciences Corporation, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6

    Protein Sciences Corporation, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7

    Protein Sciences Corporation, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8

    Protein Sciences Corporation, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9

    Protein Sciences Corporation, Pharmaceuticals & Healthcare, Deal Details 10

    Partnerships 10

    Protein Sciences Enters into Co-Development Agreement with Sinergium Biotech and Mundo Sano 10

    Licensing Agreements 11

    Orygen Biotecnologia Enters into Licensing Agreement with Protein Sciences for Flublok 11

    Protein Sciences Enters into Licensing Agreement with Liomont for Flublok and Panblok 12

    uniQure Enters Into Licensing Agreement With Protein Sciences For expresSF+ Insect Cell Technology 14

    Merck Enters Into Licensing Agreement With Protein Sciences For expresSF+ Insect Cell Technology 15

    Protein Sciences Expands Its Licensing Agreement With UMN Pharma For FluBlok And PanBlok 16

    Protein Sciences Corporation - Key Competitors 17

    Key Employees 18

    Locations And Subsidiaries 19

    Head Office 19

    Appendix 20

    Methodology 20

    About GlobalData 20

    Contact Us 20

    Disclaimer 20

List Of Tables
in Protein Sciences Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile

List of Tables

Protein Sciences Corporation, Pharmaceuticals & Healthcare, Key Facts 1

Protein Sciences Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5

Protein Sciences Corporation, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6

Protein Sciences Corporation, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7

Protein Sciences Corporation, Deals By Therapy Area, 2010 to YTD 2016 8

Protein Sciences Corporation, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9

Protein Sciences Enters into Co-Development Agreement with Sinergium Biotech and Mundo Sano 10

Orygen Biotecnologia Enters into Licensing Agreement with Protein Sciences for Flublok 11

Protein Sciences Enters into Licensing Agreement with Liomont for Flublok and Panblok 12

uniQure Enters Into Licensing Agreement With Protein Sciences For expresSF+ Insect Cell Technology 14

Merck Enters Into Licensing Agreement With Protein Sciences For expresSF+ Insect Cell Technology 15

Protein Sciences Expands Its Licensing Agreement With UMN Pharma For FluBlok And PanBlok 16

Protein Sciences Corporation, Key Competitors 17

Protein Sciences Corporation, Key Employees 18

List Of Figures, Charts and Diagrams
in Protein Sciences Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile

List of Figures

Protein Sciences Corporation, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1

Protein Sciences Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1

Protein Sciences Corporation, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1

Protein Sciences Corporation, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1

Protein Sciences Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5

Protein Sciences Corporation, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6

Protein Sciences Corporation, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7

Protein Sciences Corporation, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8

Additional Details

Publisher

Global Data

Publisher Information

Reference

12781 | GDPH138579D

Number of Pages

20

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Cathepsin L1 (Cathepsin L or Major Excreted Protein or CTSL or EC 3.4.22.15) - Pipeline Review, H2 2016
Cathepsin L1 (Cathepsin L or Major Excreted Protein or CTSL or EC 3.4.22.15) - Pipeline Review, H2 2...
26 Oct 2016 by Global Markets Direct USD $3,500 More Info
Prostaglandin D2 Receptor 2 (Chemoattractant Receptor Homologous Molecule Expressed On Th2 Cells or G Protein Coupled Receptor 44 or GPR44 or CD294 or PTGDR2) - Pipeline Review, H2 2016
Prostaglandin D2 Receptor 2 (Chemoattractant Receptor Homologous Molecule Expressed On Th2 Cells or ...
26 Oct 2016 by Global Markets Direct USD $3,500 More Info
Superoxide Dismutase [Cu-Zn] (Superoxide Dismutase 1 or Epididymis Secretory Protein Li 44 or SOD1 or EC 1.15.1.1) - Pipeline Review, H2 2016
Superoxide Dismutase [Cu-Zn] (Superoxide Dismutase 1 or Epididymis Secretory Protein Li 44 or SOD1 o...
26 Oct 2016 by Global Markets Direct USD $3,500 More Info
Placenta Growth Factor (Vascular Endothelial Growth Factor Related Protein or PGF) - Pipeline Review, H2 2016
Placenta Growth Factor (Vascular Endothelial Growth Factor Related Protein or PGF) - Pipeline Review...
26 Oct 2016 by Global Markets Direct USD $3,500 More Info
Tyrosine Protein Kinase BTK (Bruton Tyrosine Kinase or B Cell Progenitor Kinase or Agammaglobulinemia Tyrosine Kinase or BTK or EC 2.7.10.2) - Pipeline Review, H2 2016
Tyrosine Protein Kinase BTK (Bruton Tyrosine Kinase or B Cell Progenitor Kinase or Agammaglobulinemi...
26 Oct 2016 by Global Markets Direct USD $3,500 More Info
Protagen Protein Services GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryProtagen Protein Services GmbH (PPS), a subsidiary of Zukunftsfonds Heilbronn GmbH & Co. KG, ...
12 May 2016 by Global Data USD $250 More Info
Protein Sciences Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryProtein Sciences Corporation (Protein Sciences) is a biotechnology company that develops and ...
15 Mar 2016 by Global Data USD $250 More Info
Protagen Protein Services GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryProtagen Protein Services GmbH (PPS) is a contract research organization that focuses on prot...
15 Mar 2016 by Global Data USD $250 More Info
Electrophoresis Reagents Market by Product (Dyes (EtBr & SYBR) Gels (Polyacrylamide, Starch, & Agarose) Buffer (TBE & TAE)) by Application (Protein Analysis, DNA & RNA Analysis) by Technique (Gel & Capillary Electrophoresis) - Global Forecast to 2020
The global electrophoresis reagents market is expected to grow at a CAGR of 5.4% during the forecast...
15 Feb 2016 by MarketsandMarkets USD $4,650 More Info
Protein Labeling Market by Product (Reagents, Kits, & Services), Labeling Method (In Vitro Labeling, In Vivo Labeling), Application (Cell-Based Assay, Fluorescence Microscopy, Immunological Technique), & Region - Global Forecast to 2020
The global protein labeling market is expected to reach USD 1,894.5 million by 2020 from USD 1,089.5...
04 Dec 2015 by MarketsandMarkets USD $4,650 More Info

This report is published by Global Data

Download Free Report Summary PDF

Protein Sciences Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...